OrganonOGN +0.22%73 OCF Yield % is 24.01 as of Jun. 25, 2026, which is 6% above its 10-year median of 22.75. GuruFocus rates OGN with a GF Score™ of 73/100 and a GF Value™ of $14.55 (Fairly Valued). The stock has 9 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Organon ranks better than 94.23% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Organon OCF Yield % Related Terms
Organon OCF Yield % Historical Data
* Premium members only.
The historical data trend for Organon's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Organon's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organon OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organon's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Organon's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organon (OGN) has a OCF Yield % of 24.01 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Organon and its competitors. This is near median its historical median of 22.75. Over the past decade, Organon's OCF Yield % has ranged from 7.88 to 53.94. According to the industry distribution chart, Organon ranks #58 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 5.8%.
Is Organon's OCF Yield % too high?
Organon's current OCF Yield % of 24.01 is near median its 10-year median of 22.75. Over the past 10 years, this metric has ranged from a low of 7.88 to a high of 53.94. The Drug Manufacturers industry median OCF Yield % is 3.57. Organon's value of 24.01 is 572.5% above this industry median. Based on the distribution chart, Organon ranks #58 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Organon has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Organon's OCF Yield % compare to AMRN and SCLX?
According to the Drug Manufacturers industry distribution chart, Organon ranks #58 out of 1005 companies for OCF Yield %. This places Organon in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.57. Organon's value of 24.01 is 572.5% above this benchmark. Historically, Organon's own OCF Yield % has ranged from 7.88 to 53.94 over the past decade. While the company's 10-year median is 22.75 vs. the industry median of 3.57, Organon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.57, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organon's current OCF Yield % of 24.01 is 572.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Organon and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organon's current OCF Yield % is 24.01, which is near median its own 10-year median of 22.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (OGN) is currently considered Fairly Valued. The stock's GF Value™ is $14.55, compared to a current price of $13.48 — trading 7.4% below its estimated fair value. The current OCF Yield % is 24.01, which is near median its 10-year median of 22.75 and 572.5% above the Drug Manufacturers industry median of 3.57. Organon's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Organon (OGN), the current OCF Yield % is 24.01 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organon (OGN) Overvalued in 2026?
Based on GuruFocus' analysis, Organon stock appears to be undervalued.
The current stock price of $13.48 is trading 7.4% below its estimated GF Value™ of $14.55.
GuruFocus considers Organon to be Fairly Valued.
Key valuation signals for OGN:
OCF Yield %: 24.01 (near median its 10-year median of 22.75)
GF Value™: $14.55 vs. price of $13.48 (7.4% below fair value)
Industry Position: 572.5% above the Drug Manufacturers median (#58 of 1005)
No single metric tells the full story. See the OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
73GF Score
Get the complete analysis for OGN
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OGN has been successfully added to your 
